GSK Income Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Sep '24 Sep 30, 2024	Jun '24 Jun 30, 2024	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023	Jun '23 Jun 30, 2023	Mar '23 Mar 31, 2023	Dec '22 Dec 31, 2022	Sep '22 Sep 30, 2022	Jun '22 Jun 30, 2022	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Sep '21 Sep 30, 2021
Revenue	8,409	7,629	8,618	8,547	7,986	7,516	8,117	8,012	7,884	7,363	8,052	8,147	7,178	6,951	7,376	7,829	6,929	7,190	7,076	6,627
Revenue Growth (YoY)	5.30%	1.50%	6.17%	6.68%	1.29%	2.08%	0.81%	-1.66%	9.84%	5.93%	9.16%	4.06%	3.59%	-3.32%	4.24%	18.14%	18.69%	39.48%	-19.03%	-23.35%
Cost of Revenue	2,266	1,875	2,657	2,258	2,165	1,937	2,559	2,397	2,122	1,970	2,418	2,272	1,932	1,943	2,238	2,423	2,176	2,717	2,785	2,016
Gross Profit	6,143	5,754	5,961	6,289	5,821	5,579	5,558	5,615	5,762	5,393	5,634	5,875	5,246	5,008	5,138	5,406	4,753	4,473	4,291	4,611
Selling, General & Admin	2,202	2,119	2,639	2,239	2,140	2,070	2,663	3,800	2,465	2,087	2,678	2,296	2,268	2,143	2,438	2,056	2,066	1,812	2,193	1,679
Research & Development	3,466	1,692	2,350	1,689	2,024	1,462	2,031	1,459	1,477	1,434	2,047	1,575	1,341	1,260	1,797	1,346	1,242	1,103	1,376	1,416
Other Operating Expenses	-6	-350	-128	-232	-366	-169	168	167	174	382	336	55	-504	-477	-965	813	364	-735	230	136
Total Operating Expenses	5,662	3,461	4,861	3,696	3,798	3,363	4,862	5,426	4,116	3,903	5,061	3,926	3,105	2,926	3,270	4,215	3,672	2,180	3,799	3,231
Operating Income	481	2,293	1,100	2,593	2,023	2,216	696	189	1,646	1,490	573	1,949	2,141	2,082	1,868	1,191	1,081	2,293	492	1,380
Interest Income	58	22	39	26	50	54	34	32	24	32	29	24	33	29	26	22	21	7	1	4
Interest Expense	-182	-167	-188	-167	-184	-162	-173	-156	-174	-166	-222	-182	-185	-203	-270	-200	-204	-205	-188	-195
Other Non-Operating Income (Expense)	-3	-4	-1	4	-2	-	6	-1	-1	-1	-1	-	-2	-1	2	-1	-2	-1	-2	3
Total Non-Operating Income (Expense)	-127	-149	-150	-137	-136	-108	-133	-125	-151	-135	-194	-158	-154	-175	-242	-179	-185	-199	-189	-188
Pretax Income	354	2,144	950	2,456	1,887	2,108	563	64	1,495	1,355	379	1,791	1,987	1,907	1,626	1,012	896	2,094	303	1,192
Provision for Income Taxes	-199	305	223	312	241	336	62	-1	191	274	-19	257	242	276	1	233	150	323	-117	246
Net Income	553	1,839	727	2,144	1,646	1,772	501	65	1,304	1,081	398	1,534	1,745	1,631	1,625	779	746	1,771	420	946
Minority Interest in Earnings	118	102	91	131	203	148	87	123	131	35	48	70	121	141	125	38	137	365	181	200
Earnings From Discontinued Operations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-5	9,574	229	396	510	422
Net Income to Common	435	1,737	636	2,013	1,443	1,624	414	-58	1,173	1,046	350	1,464	1,624	1,490	1,495	10,315	838	1,802	749	1,168
Net Income Growth (YoY)	-69.85%	6.96%	53.62%	-	23.02%	55.26%	18.29%	-	-27.77%	-29.80%	-76.59%	-85.81%	93.80%	-17.31%	99.60%	783.13%	-39.93%	67.94%	10.63%	-6.11%
Shares Outstanding (Basic)	2,007	2,012	2,010	2,017	2,032	2,044	2,041	2,040	2,040	2,035	2,028	2,028	2,027	2,022	2,017	2,015	2,013	2,008	2,004	2,003
Shares Outstanding (Diluted)	2,031	2,037	2,043	2,051	2,055	2,069	2,073	2,071	2,061	2,057	2,058	2,056	2,047	2,043	2,046	2,044	2,032	2,033	2,029	2,027
Shares Change (YoY)	-1.17%	-1.52%	-1.42%	-0.94%	-0.29%	0.58%	0.70%	0.70%	0.71%	0.69%	0.61%	0.59%	0.71%	0.47%	0.84%	0.84%	0.64%	0.90%	0.58%	0.55%
EPS (Basic)	0.22	0.86	0.32	1.00	0.71	0.79	0.20	-0.03	0.58	0.51	0.17	0.72	0.80	0.74	0.74	5.12	0.42	0.90	0.37	0.58
EPS (Diluted)	0.21	0.85	0.31	0.98	0.70	0.79	0.20	-0.03	0.57	0.51	0.17	0.71	0.79	0.73	0.73	5.05	0.41	0.89	0.37	0.58
EPS Growth (YoY)	-69.52%	8.40%	56.00%	-	23.16%	54.72%	17.65%	-	-28.21%	-30.41%	-76.71%	-85.89%	92.72%	-17.79%	97.30%	776.04%	-40.29%	66.76%	10.45%	-6.72%
Free Cash Flow	2,690	920	1,705	2,222	2,096	937	1,785	1,849	811	710	2,710	1,913	1,011	-180	1,467	1,046	1,398	2,349	3,171	2,338
Free Cash Flow Growth (YoY)	28.34%	-1.81%	-4.48%	20.17%	158.45%	31.97%	-34.13%	-3.35%	-19.78%	-	84.73%	82.89%	-27.68%	-	-53.74%	-55.26%	22.52%	1706.92%	-5.09%	310.90%
Free Cash Flow Per Share	1.32	0.45	0.83	1.08	1.02	0.45	0.86	0.89	0.39	0.35	1.32	0.93	0.49	-0.09	0.72	0.51	0.69	1.16	1.56	1.15
Dividends Per Share	-	0.170	0.180	0.160	0.160	0.160	0.160	0.150	0.150	0.150	0.160	0.140	0.140	0.140	0.138	0.138	0.163	0.175	0.287	0.237
Dividend Growth (YoY)	-	6.25%	12.50%	6.67%	6.67%	6.67%	0%	7.14%	7.14%	7.14%	16.36%	1.82%	-13.85%	-20.00%	-52.17%	-42.10%	-31.58%	-26.32%	0%	0%
Gross Margin	73.05%	75.42%	69.17%	73.58%	72.89%	74.23%	68.47%	70.08%	73.08%	73.24%	69.97%	72.11%	73.08%	72.05%	69.66%	69.05%	68.60%	62.21%	60.64%	69.58%
Operating Margin	5.72%	30.06%	12.76%	30.34%	25.33%	29.48%	8.57%	2.36%	20.88%	20.24%	7.12%	23.92%	29.83%	29.95%	25.33%	15.21%	15.60%	31.89%	6.95%	20.82%
Profit Margin	6.58%	24.11%	8.44%	25.08%	20.61%	23.58%	6.17%	0.81%	16.54%	14.68%	4.94%	18.83%	24.31%	23.46%	22.03%	9.95%	10.77%	24.63%	5.94%	14.27%
FCF Margin	31.99%	12.06%	19.78%	26.00%	26.25%	12.47%	21.99%	23.08%	10.29%	9.64%	33.66%	23.48%	14.08%	-2.59%	19.89%	13.36%	20.18%	32.67%	44.81%	35.28%
EBITDA	481	2,293	1,100	2,593	2,023	2,216	696	189	1,646	1,490	573	1,949	2,141	2,082	1,868	1,191	1,081	2,293	492	1,380
EBIT	481	2,293	1,100	2,593	2,023	2,216	696	189	1,646	1,490	573	1,949	2,141	2,082	1,868	1,191	1,081	2,293	492	1,380
EBIT Margin	5.72%	30.06%	12.76%	30.34%	25.33%	29.48%	8.57%	2.36%	20.88%	20.24%	7.12%	23.92%	29.83%	29.95%	25.33%	15.21%	15.60%	31.89%	6.95%	20.82%
Effective Tax Rate	-56.21%	14.23%	23.47%	12.70%	12.77%	15.94%	11.01%	-1.56%	12.78%	20.22%	-5.01%	14.35%	12.18%	14.47%	0.06%	23.02%	16.74%	15.43%	-38.61%	20.64%

SEC Filings: 10-K · 10-Q